Chan Joel Ern Zher, Olakkengil Kate S, Bhattacharjya Shantanu, Olakkengil Santosh Antony
Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Central and Northern Adelaide Renal and Transplantation Services, Adelaide, South Australia, Australia.
ANZ J Surg. 2025 Jul-Aug;95(7-8):1597-1604. doi: 10.1111/ans.70134. Epub 2025 Apr 22.
The prevalence of intracranial aneurysms (ICAs) is higher in patients with autosomal dominant polycystic kidney disease (ADPKD) than in the general population. This extrarenal manifestation carries significant mortality and morbidity risks. Our study aims to estimate the prevalence of, and to characterize patients with ICA(s) among the ADPKD cohort of South Australia's statewide transplantation centre.
A retrospective review of prospectively collected data was conducted for all patients who underwent nephrectomy/ies between 1 January 1995 and 31 December 2021. Incidences of neuroimaging and radiologically diagnosed ICAs, and the presence of risk factors including family history are compared between ADPKD patients and those with an alternate primary nephrological diagnosis (control). Descriptive statistics and a narrative review of cases are presented.
Seven patients had ICAs (14.3% ADPKD patients, 23.3% those with neuroimaging). Six did not meet current criteria for ICA screening, and five had no known family history of ICA. Three patients suffered aneurysmal rupture (mean age of 36). Two of these cases involved smaller ICAs. Cases demonstrated detectable vascular changes on early neuroimaging, hypoplastic anatomical variants, aneurysmal growth, de novo ICA formation, and association with other vascular abnormalities.
Early detection of ICAs and pre-aneurysmal changes should be prioritized in ADPKD. Although limited by the small study cohort, our findings are consistent with previous literature suggesting ICA ruptures occur earlier in ADPKD and in smaller aneurysms. Further investigation is required into how these ICAs behave. Nonetheless, it is vital that centres coordinate a multidisciplinary, patient-centred approach to ICA screening, surveillance, and management for ADPKD patients.
常染色体显性遗传性多囊肾病(ADPKD)患者颅内动脉瘤(ICA)的患病率高于普通人群。这种肾外表现具有显著的死亡和发病风险。我们的研究旨在估计南澳大利亚全州移植中心ADPKD队列中ICA的患病率,并对ICA患者进行特征描述。
对1995年1月1日至2021年12月31日期间接受肾切除术的所有患者进行前瞻性收集数据的回顾性研究。比较ADPKD患者与原发性肾病诊断不同的患者(对照组)之间神经影像学和经放射学诊断的ICA的发生率,以及包括家族史在内的危险因素的存在情况。给出描述性统计数据并对病例进行叙述性回顾。
7例患者患有ICA(ADPKD患者中占14.3%,神经影像学检查患者中占23.3%)。6例不符合当前ICA筛查标准,5例无已知ICA家族史。3例患者发生动脉瘤破裂(平均年龄36岁)。其中2例涉及较小的ICA。病例显示早期神经影像学上可检测到血管变化、发育不全的解剖变异、动脉瘤生长、新发ICA形成以及与其他血管异常的关联。
ADPKD患者应优先早期检测ICA和动脉瘤前变化。尽管本研究队列较小,但我们的发现与先前文献一致,提示ADPKD患者ICA破裂发生更早且动脉瘤更小。需要进一步研究这些ICA的行为方式。尽管如此,各中心协调针对ADPKD患者的ICA筛查、监测和管理的多学科、以患者为中心的方法至关重要。